No title
Abstract This paper discusses protectionism of intellectual property rights in general and the conflict between large pharmaceutical companies’ rights to patent and developing countries’ rights to cheap generic preparation in particular. The essay focuses above all on HIV/AIDS medicine. The description tries to give an image of the different interests that collide and why they collide. The differe
